I just shared a new analysis of Japan’s hospital-operating medical corporations (FY2016–2022).
• Corporations decreased from 4,631 → 4,469
• FY2022 assets: 15.9 trillion JPY; revenues: 12.5 trillion JPY
• Smaller corporations were less resilient, especially during COVID-19
#J_Epidemi Advanced Publication:
Financial Performance of Medical Corporations in Japan from 2016 to 2022: A Nationwide Longitudinal Analysis
Satoshi Funada et al.
https://t.co/3XnBp5nFC6
@J_Epidemi@funada_satoshi
Our paper has been published. In this longitudinal study, we find that between 2017 and 2021, horizontal and vertical integration gradually progressed in medical corporations.|BMC Health Services Research|https://t.co/DV7oZ7nn0I
We are excited to present our latest research findings on the efficacy of multicomponent therapy for overactive bladder, as demonstrated through an RCT. This study highlights the efficacy of this approach in the management of moderate-to-severe OAB.
This randomized clinical trial provides evidence to support multi-component intervention with cognitive components as an effective treatment option for women with moderate-to-severe overactive bladder. https://t.co/ujU81B9SV5
【New paper on ECPR】
We are thrilled to introduce our new research paper published in Critical Care! @Crit_Care
https://t.co/UCFc7HxebH
This study indicated the association between ECPR and survival among patients with out-of-hospital cardiac arrest.
Detection bias in open-label trials of anticancer drugs: a meta-epidemiological study
Original Research by @funada_satoshi, @yluo06, @YukiKataoka3 and colleagues
#OpenAccess
Link: https://t.co/WDVzb7vlBe
We have finally published a #SystematicReview that evaluates the benefits and harms of bladder training for treating adults with Overactive bladder (OAB).
https://t.co/B1b0m2wFfv
@CochraneLibrary